Cargando…

Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry

BACKGROUND: Non‐statin lipid lowering therapies (LLTs) provide additional treatment options for patients. Use patterns and patient perceptions of non‐statin LLT remain incompletely described. HYPOTHESIS: The guideline‐recommended statin intensity remains underutilized in patients treated with and wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lowenstern, Angela, Li, Shuang, Navar, Ann Marie, Virani, Salim S., Roger, Veronique L., Robinson, Jennifer G., Goldberg, Anne C., Kampman, Wendy, Peterson, Eric D., Wang, Tracy Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207979/ https://www.ncbi.nlm.nih.gov/pubmed/34008247 http://dx.doi.org/10.1002/clc.23625

Ejemplares similares

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
por: Bradley, Corey K., et al.
Publicado: (2019)

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
por: Xian, Ying, et al.
Publicado: (2019)

Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry
por: Lowenstern, Angela M., et al.
Publicado: (2018)

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
por: Nanna, Michael G., et al.
Publicado: (2018)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US
por: Cannon, Christopher P., et al.
Publicado: (2021)

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects
por: Ahmed, Sarah T., et al.
Publicado: (2020)

Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases
por: Deo, Salil V., et al.
Publicado: (2023)

Association Between Statin Use and Progression of Arterial Stiffness Among Adults With High Atherosclerotic Risk
por: Zhou, Yan-Feng, et al.
Publicado: (2022)

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease
por: Gobbel, Glenn T., et al.
Publicado: (2021)

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
por: Yao, Xiaoxi, et al.
Publicado: (2020)

CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
por: Jia, Xiaoming, et al.
Publicado: (2019)

Prescribing of Statins After Lower Extremity Revascularization Procedures in the US
por: Singh, Nikhil, et al.
Publicado: (2021)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2021)

Should all patients with psoriasis receive statins? Analysis according to different strategies()()
por: Masson, Walter, et al.
Publicado: (2019)

Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
por: Shen, Yun, et al.
Publicado: (2020)

Patient Preference Distribution for Use of Statin Therapy
por: Brodney, Suzanne, et al.
Publicado: (2021)

Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
por: Jia, Xiaoming, et al.
Publicado: (2021)

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Rethinking Cognitive Impairment in the Management of Older Patients With Cardiovascular Disease
por: Lowenstern, Angela, et al.
Publicado: (2019)

Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
por: Hatipsoylu, Erdinç, et al.
Publicado: (2019)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Controlling the thickness of the atherosclerotic plaque by statin medication
por: Formanowicz, Dorota, et al.
Publicado: (2020)

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease
por: Sajja, Aparna, et al.
Publicado: (2021)

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry
por: Sciria, Christopher T., et al.
Publicado: (2020)

Patterns and predictors of statin prescription in patients with type 2 diabetes
por: Berthold, Heiner K, et al.
Publicado: (2009)

Prospective evaluation of lipid management following acute coronary syndrome in non‐Western countries
por: Navar, Ann Marie, et al.
Publicado: (2021)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021)

Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease
por: Nicolajsen, Chalotte W., et al.
Publicado: (2023)

Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
por: Borne, Ryan T., et al.
Publicado: (2021)

Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan
por: Yeh, Yen-Ting, et al.
Publicado: (2017)

Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
por: Bae, Han Joon, et al.
Publicado: (2020)

Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy
por: Rea, Federico, et al.
Publicado: (2021)

Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Fetterman, Jessica L., et al.
Publicado: (2016)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lqrbsp2p42ob13gjm40sing0np